The spectrum of B-cell non-Hodgkin lymphomas with dual IgH-BCL2 and BCL6 translocations

American Journal of Clinical Pathology

Volumn 130, Issue 2, 2008, Pages 193-201

  Keller, Christian E ^a   Nandula, Subhadra ^a   Fisher, Julie ^a   Subramaniyam, Shivakumar ^a   Vakiani, Efsevia ^a   Savage, David G ^a   Murty, Vundavalli V ^a   Alobeid, Bachir ^a   Bhagat, Govind ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NONE   (United States)

Author keywords

BCL2; BCL6; Dual translocation; Non Hodgkin lymphoma; Oncogene

Indexed keywords

BCL2 RELATED PROTEIN A1; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; INTERFERON REGULATORY FACTOR 4; PROTEIN BCL 6;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BCL6 GENE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; GENE; GENE TRANSLOCATION; GENETIC VARIABILITY; GERMINAL CENTER; HUMAN; HUMAN TISSUE; IGH BCL2 GENE; IMMUNOHISTOCHEMISTRY; KARYOTYPING; MALE; MORPHOLOGY; NONHODGKIN LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; SPECTRUM;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; GENES, BCL-2; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-6; TRANSLOCATION, GENETIC;

EID: 48649101364     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/ELPKF130Q0MCMWU8     Document Type: Article

References (50)

1. Jaffe ES, Harris NL, Stein H, et al. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:352. World Health Organization Classification of Tumours.
2. Willis TG, Dyer MJ. The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood. 2000;96:808-822.
3. Biagi JJ, Seymour JF. Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation. Blood. 2002;99:4265-4275.
4. Horsman DE, Okamoto I, Ludkovski O, et al. Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes. Br J Haematol. 2003;120:424-433.
5. Jardin F, Gaulard P, Buchonnet G, et al. Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristics. Leukemia. 2002;16:2309-2317.
6. Bosga-Bouwer AG, van Imhoff GW, Boonstra R, et al. Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive. Blood. 2003;101:1149-1154.
7. Ott G, Katzenberger T, Lohr A, et al. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood. 2002;99:3806-3812.
8. Huang JZ, Sanger WG, Greiner TC, et al. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood. 2002;99:2285-2290.
9. Polo JM, Juszczynski P, Monti S, et al. Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomas. Proc Natl Acad Sci U S A. 2007;104:3207-3212.
10. Hebert J, Romana SP, Hillion J, et al. Translocation t(3;22) (q27;q11) in non-Hodgkin's malignant lymphoma: chromosome painting and molecular studies. Leukemia. 1993;7:1971-1974.
11. Ueda C, Nishikori M, Kitawaki T, et al. Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma. Int J Hematol. 2004;79:2-54.
12. Johansson B, Mertens F, Mitelman F. Cytogenetic evolution patterns in non-Hodgkin's lymphoma. Blood. 1995;86:3905-3914.
13. Okano A, Nakano S, Namura K, et al. Unique three-way translocation, t(3;14;18)(q27;q32;q21), in follicular lymphoma. Cancer Genet Cytogenet. 2005;159:174-176.
14. Rack K, Delannoy A, Ravoet C, et al. Translocation of BCL2 and BCL6 to the same immunoglobulin heavy chain locus in a case of follicular lymphoma. Leuk Lymphoma. 2005;46:1513-1516.
15. Bastard C, Tilly H, Lenormand B, et al. Translocations involving band 3q27 and Ig gene regions in non-Hodgkin's lymphoma. Blood. 1992;79:527-2531.
16. Otsuki T, Yano T, Clark HM, et al. Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: results of rearrangement and gene expression studies and a mutational analysis of coding region sequences. Blood. 1995;85:2877-2884.
17. Dave BJ, Nelson M, Pickering DL, et al. Cytogenetic characterization of diffuse large cell lymphoma using multicolor fluorescence in situ hybridization. Cancer Genet Cytogenet. 2002;132:125-132.
18. Lossos IS, Levy R. Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions. Semin Cancer Biol. 2003;13:191-202.
19. Lossos IS, Warnke R, Levy R. BCL-6 mRNA expression in higher grade transformation of follicle center lymphoma: correlation with somatic mutations in the 59 regulatory region of the BCL-6 gene. Leukemia. 2002;16:1857-1862.
20. Akasaka T, Lossos IS, Levy R. BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. Blood. 2003;102:1443-1448.
21. Martinez-Climent JA, Alizadeh AA, Segraves R, et al. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood. 2003;101:3109-3117.
22. Shaffer LG, Tommerup N. ISCN. 2005: An International System for Human Cytogenetic Nomenclature (2005). Basel, Switzerland: Karger; 2005:130.
23. Keller CE, Nandula S, Vakiani E, et al. Intrachromosomal rearrangement of chromosome 3q27: an under recognized mechanism of BCL6 translocation in B-cell non-Hodgkin lymphoma. Hum Pathol. 2006;37:1093-1099.
24. Kuppers R, Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene. 2001;20:5580-5594.
25. Ong ST, Le Beau MM. Chromosomal abnormalities and molecular genetics of non-Hodgkin's lymphoma. Semin Oncol. 1998;25:447-460.
26. Hoglund M, Sehn L, Connors JM, et al. Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas. Genes Chromosomes Cancer. 2004;39:195-204.
27. Voorhees PM, Carder KA, Smith SV, et al. Follicular lymphoma with a Burkitt translocation: predictor of an aggressive clinical course: a case report and review of the literature. Arch Pathol Lab Med. 2004;128:210-213.
28. Daudignon A, Bisiau H, Le Baron F, et al. Four cases of follicular lymphoma with t(14;18)(q32;q21) and t(3;4)(q27;p13) with LAZ3 (BCL6) rearrangement. Cancer Genet Cytogenet. 1999;111:157-160.
29. Horsman DE, McNeil BK, Anderson M, et al. Frequent association of t(3;14) or variant with other lymphoma-specific translocations. Br J Haematol. 1995;89:569-575.
30. Au WY, Gascoyne RD, Viswanatha DS, et al. Concurrent chromosomal alterations at 3q27, 8q24 and 18q21 in B-cell lymphomas. Br J Haematol. 1999;105:437-440.
31. Lai JL, Daudignon A, Kerckaert JP, et al. Translocation (3;13) (q27;q14): a nonrandom and probably secondary structural change in non-Hodgkin lymphomas. Cancer Genet Cytogenet. 1998;103:140-143.
32. Offit K, Jhanwar S, Ebrahim SA, et al. t(3;22)(q27;q11): a novel translocation associated with diffuse non-Hodgkin's lymphoma. Blood. 1989;74:1876-1879.
33. Bastard C, Deweindt C, Kerckaert JP, et al. LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood. 1994;83:2423-2427.
34. Whang-Peng J, Knutsen T, Jaffe ES, et al. Sequential analysis of 43 patients with non-Hodgkin's lymphoma: clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies. Blood. 1995;85:203-216.
35. Wlodarska I, Mecucci C, Stul M, et al. Fluorescence in situ hybridization identifies new chromosomal changes involving 3q27 in non-Hodgkin's lymphomas with BCL6/LAZ3 rearrangement. Genes Chromosomes Cancer. 1995;14:1-7.
36. Muramatsu M, Akasaka T, Kadowaki N, et al. Rearrangement of the BCL6 gene in B-cell lymphoid neoplasms: comparison with lymphomas associated with BCL2 rearrangement. Br J Haematol. 1996;93:911-920.
37. Kramer MH, Hermans J, Wijburg E, et al. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood. 1998;92:3152-3162.
38. Bende RJ, Smit LA, van Noesel CJ. Molecular pathways in follicular lymphoma. Leukemia. 2007;21:18-29.
39. Bosga-Bouwer AG, Haralambieva E, Booman M, et al. BCL6 alternative translocation breakpoint cluster region associated with follicular lymphoma grade 3B. Genes Chromosomes Cancer. 2005;44:301-304.
40. Butler MP, Iida S, Capello D, et al. Alternative translocation breakpoint cluster region 5′ to BCL-6 in B-cell non-Hodgkin's lymphoma. Cancer Res. 2002;62:4089-4094.
41. Nathwani BN, Piris MA, Harris NL, et al. Follicular lymphoma. In Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:162-167. World Health Organization Classification of Tumours.
42. Osborne BM, Butler JJ. Follicular lymphoma mimicking progressive transformation of germinal centers. Am J Clin Pathol. 1987;88:264-269.
43. Garcia JF, Mollejo M, Fraga M, et al. Large B-cell lymphoma with Hodgkin's features. Histopathology. 2005;47:101-110.
44. Eshoa C, Perkins S, Kampalath B, et al. Decreased CD10 expression in grade III and in interfollicular infiltrates of follicular lymphomas. Am J Clin Pathol. 2001;115:862-867.
45. Guo Y, Karube K, Kawano R, et al. Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances. Leukemia. 2005;19:1058-1063.
46. Barry TS, Jaffe ES, Kingma DW, et al. CD5+ follicular lymphoma: a clinicopathologic study of three cases. Am J Clin Pathol. 2002;118:589-598.
47. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275-282.
48. Iqbal J, Greiner TC, Patel K, et al. Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia. 2007;21:2332-2343.
49. Offit K, Lo Coco F, Louie DC, et al. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med. 1994;331:74-80.
50. Akasaka T, Ueda C, Kurata M, et al. Nonimmunoglobulin (non-Ig)/BCL6 gene fusion in diffuse large B-cell lymphoma results in worse prognosis than Ig/BCL6. Blood. 2000;96:2907-2909.